In a symposium1 focused on healthcare cost control, most of our authors have unsur prisingly highlighted and assessed Obamacare’s payment and delivery reforms—the supply-side efforts to decrease costs of medical treatment.2 But there is another party in healthcare decision-making who is equally or even more important: the patient. The question we will tackle here is whether the individual m…